NASDAQ · Shell Companies

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Stock

$10.68 +0.09% NASDAQ: DMAA Financial Services

Drugs Made In America Acquisition Corp. does not have significant operations.

Valuation

MetricValue
Price$10.68
Market Cap$360.10M
P/E Ratio52.20
P/B Ratio1.05
P/S Ratio0.00
EPS (TTM)$0.20
52-Week High$10.69
52-Week Low$10.21
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE2.88%
ROA2.75%
ROCE-1.09%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.03

Annual Financials (USD)

Metric20242025
Revenue$0$0
Operating Profit$0$-3.0M
Net Profit$0$6.0M
EPS$-0.06$0.19
Op Margin——

Balance Sheet (USD)

Metric20242025
Total Assets$0$240.0M
Total Liabilities$0$7.0M
Cash$0$0
Borrowings$0$0

Cash Flow (USD)

Metric20242025
Operating Cash Flow$0$-1.0M
Investing Cash Flow$0$-231.0M
Financing Cash Flow$0$1.0M
Net Cash Flow$0$0
Free Cash Flow$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.52
EV / EBITDA-137.04
FCF Yield-0.11%
Quick Ratio0.03
Interest Coverage0.00
Return 1Y4.09%
Return 3Y—
Return 5Y—

Ownership

Insiders Held23.57%
Institutions Held98.26%
Institutions Float Held128.56%
Institutional HolderSharesReport Date
Karpus Management, Inc.2,530,5172026-03-31
First Trust Capital Management L.P.2,242,5002026-03-31
Mizuho Securities USA LLC2,000,0002026-03-31
Glazer Capital LLC1,678,4062026-03-31
Westchester Capital Management, LLC1,669,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALFCenturion Acquisition Corp. $10.89 -0.55% 34.45 $391.36M 0.00%
LOKVLive Oak Acquisition Corp. V Class A Ordinary Shares $11.52 +0.00% -33.50 $331.20M 0.00%
MLACMountain Lake Acquisition Corp. Class A $0.98 -16.24% 3.72 $30.37M 0.00%
OYSEOyster Enterprises II Acquisition Corp $10.34 +0.49% 34.30 $350.67M 0.00%
RTACRenatus Tactical Acquisition Corp I Class A Ordinary Shares $10.57 +0.09% 41.76 $329.37M 0.00%

About Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Drugs Made In America Acquisition Corp. Ordinary Shares is headquartered in US.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) stock trades at $10.68 with a market capitalization of $360.10M. The stock is valued at a price-to-earnings (P/E) ratio of 52.20, price-to-book of 1.05, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $10.21 and $10.69, and currently trades at its 52-week high.

On profitability, Drugs Made In America Acquisition Corp. Ordinary Shares generates a return on equity (ROE) of 2.88%, return on capital employed of -1.09%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: dmaacorp.com

Related Financial Services Stocks

BRK.A Berkshire Hathaway Inc. $733370.00 +0.00% BRK.B Berkshire Hathaway Inc. New $482.70 +0.00% JPM JP Morgan Chase & Co. $332.99 +0.47% V Visa Inc. $385.45 +2.76% MA Mastercard Incorporated $589.14 +2.66% BAC Bank of America Corporation $54.32 +1.32% HSBC HSBC Holdings, plc $92.98 +0.40% MS Morgan Stanley $190.02 +1.38% RY Royal Bank Of Canada $191.91 +0.71% GS Goldman Sachs Group, Inc. (The) $895.32 +1.44% WFC Wells Fargo & Company $83.55 +1.85% MUFG Mitsubishi UFJ Financial Group, Inc. $22.38 -0.44%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)Exxon Mobil (XOM)

Screens featuring this stock

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides